Importancia clínica de los factores de crecimiento hematopoyético mieloides

Arrazola Saniger, M; Lerma García, D; Ramírez Arrazola, A; Jiménez, J. Joyanes.
Enferm. clín. (Ed. impr.) ; 12(1): 39-43, ene. 2002. tab
Artículo en Es | IBECS (España) | ID: ibc-10498

Documentos relacionados

  1. [The nurse and ethics in a diagnosis of a serious disease].
  2. Nursing measures to support the needs of haematological cancer survivors post-treatment: a literature review.
  3. Perceived need for information of patients with haematological malignancies: a literature review.
  4. Subgroup analysis in haematologic malignancies phase III clinical trials: A systematic review.
  5. Telomerase inhibition in haematological neoplasms-are we ready for primetime?
  6. [Improving nursing staff accuracy in administering chemotherapy].
  7. Developing a classification of hematologic neoplasms in the era of precision medicine.
  8. DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies.
  9. [Management of treatment-induced pain in paediatric haematology].
  10. Harnessing the power of clinician judgement. Identifying risk of deteriorating and dying in people with a haematological malignancy: A Delphi study.